Affimed to Present at the Jefferies Virtual Healthcare Conference 2021
May 26 2021 - 6:30AM
Heidelberg, Germany, May 26,
2021 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage
immuno-oncology company committed to giving patients back their
innate ability to fight cancer, announced today that its Chief
Executive Officer, Dr. Adi Hoess, will present at the Jefferies
Virtual Healthcare Conference on Wednesday, June 2, 2021 at 8:30
a.m. Eastern Time.
A live webcast of the presentation will be
accessible on Affimed’s website at
https://www.affimed.com/investors/webcasts_cp/. A replay of the
call will be archived on Affimed’s website for 30 days after the
call.
For more information on the conferences or to
schedule a one-on-one meeting with Affimed management, please
contact your conference representative or Alex Fudukidis via email
at a.fudukidis@affimed.com or phone at +1 (917) 436-8102.
About Affimed N.V.Affimed
(Nasdaq: AFMD) is a clinical-stage immuno-oncology company
committed to giving patients back their innate ability to fight
cancer by actualizing the untapped potential of the innate immune
system. The company’s proprietary ROCK® platform enables a
tumor-targeted approach to recognize and kill a range of
hematologic and solid tumors, enabling a broad pipeline of
wholly-owned and partnered single agent and combination therapy
programs. The ROCK® platform predictably generates customized
innate cell engager (ICE®) molecules, which use patients’ immune
cells to destroy tumor cells. This innovative approach enabled
Affimed to become the first company with a clinical-stage ICE®.
Headquartered in Heidelberg, Germany, with offices in New York, New
York, Affimed is led by an experienced team of biotechnology and
pharmaceutical leaders united by a bold vision to stop cancer from
ever derailing patients’ lives. For more about the company’s
people, pipeline and partners, please visit: www.affimed.com.
Affimed Investor ContactAlexander Fudukidis
Head of Investor RelationsE-Mail:
a.fudukidis@affimed.comTel.: +1 (917) 436-8102
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From Apr 2024 to May 2024
Affimed NV (NASDAQ:AFMD)
Historical Stock Chart
From May 2023 to May 2024